510(k) K081063

SENSITITRE YEASTONE SUSCEPTIBILITY PLATES- ADDITIONAL ANTIMICROBICS by Trek Diagnostic Systems, Inc. — Product Code NGZ

K081063 is an FDA 510(k) premarket notification submitted by Trek Diagnostic Systems, Inc. for the device "SENSITITRE YEASTONE SUSCEPTIBILITY PLATES- ADDITIONAL ANTIMICROBICS". The FDA issued a decision of Substantially Equivalent on Mar 6, 2009. The device falls under product code NGZ (Susceptibility Test Plate, Antifungal), a Class II device regulated under 21 CFR 866.1640. Trek Diagnostic Systems, Inc. has 67 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 6, 2009
Date Received
Apr 14, 2008
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Susceptibility Test Plate, Antifungal
Device Class
Class II
Regulation Number
866.1640
Review Panel
MI
Submission Type
510(k)

The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format.

Need the full FDA record for Trek Diagnostic Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K081063. Report a data issue: hello@regdatalab.com.